EC GMP modifications could impact CMOs

The European Commission Directorate-General for Health and Consumers issued three revisions last week that impact various aspects of drug quality and biologic active pharmaceutical ingredients. The modifications range from relatively minor such as changes in one word...

Register today for the IHIF September Life Sciences Lunch

Register today for the IHIF September Life Sciences Lunch Please join us to watch U.S Representative Erik Paulsen present updates on the new medtech tax, reforms at the Food and Drug Administration, and other issues affecting Life Science companies. When: Tuesday,...